Recursion Pharmaceuticals, Inc. in connection with consolidation of executive officer?s time at Headquarters, Dr. Shafique Virani, the Chief Business Officer transitioned into a new role as a Senior Strategic Advisor. In this role Dr. Virani will provide strategic and operational support for Recursion?s business development efforts and will continue to help drive Recursion?s mission. Dr. Virani has played a pivotal role in numerous corporate development transactions during his tenure at Recursion and is uniquely positioned to help facilitate a seamless transition.

Also on February 6, 2024, Matthew Kinn, Senior Vice President, Business Development and Corporate Initiatives joined Recursion?s executive team and assumed all responsibilities previously held by Dr. Virani. Since joining Recursion in 2017, Mr. Kinn has led numerous critical corporate development transactions spanning asset licensing, research and development collaborations with large pharma partners and technology focused partnerships. Prior to Recursion, Matt was a Principal at the Boston Consulting Group's San Francisco office in both the Technology and Healthcare practice areas.